Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-Naïve Hemodialysis Patients With Chronic Hepatitis C

NCT00491244 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

377

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a and ribavirin
DRUG: Peginterferon alfa-2a

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]